beta
Trial Radar AI
Clinical Trial NCT07474870 (CTAK) for Keratoconus, Corneal Ectasia is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Outcomes of CTAK Surgery Phase 4 100

Not yet recruiting
Clinical Trial NCT07474870 (CTAK) is designed to study Other for Keratoconus, Corneal Ectasia. This Phase 4 interventional study is not yet recruiting. Enrollment is planned to begin on 1 May 2026 until the study accrues 100 participants. Led by Stanford University, this study is expected to complete by 1 January 2031. The latest data from ClinicalTrials.gov was last updated on 16 March 2026.
Brief Summary
Measuring quality of vision and quality of life outcomes using a validated questionnaire in participants undergoing CTAK surgery for corneal ectasia
Detailed Description
We are measuring self-reported quality of vision and quality of life outcomes in participants undergoing CTAK surgery for corneal ectaisa.
Official Title

Outcomes of Corneal Tissue Addition for Keratoplasty (CTAK) in Patients With Ectatic Corneas

Conditions
KeratoconusCorneal Ectasia
Other Study IDs
  • CTAK
  • 78779
NCT ID Number
NCT07474870
Start Date (Actual)
2026-05
Last Update Posted
2026-03-16
Completion Date (Estimated)
2031-01
Enrollment (Estimated)
100
Study Type
Interventional
PHASE
Phase 4
Status
Not yet recruiting
Keywords
CTAK
Corneal Ectasia
Primary Purpose
Other
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
Participant Group/ArmIntervention/Treatment
OtherPatient reported outcomes after CTAK surgery
All subjects will complete preoperative and postoperative questionnaires
Questionnaire and Physical Exam
Patient reported outcomes of CTAK surgery
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Questionnaire
Preoperative and postoperative questionnaire
One year
Questionnaire
One year
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Corneal Ectasia and Keratoconus

  • Excessively thin cornea
  • Significant corneal scarring
Stanford University logoStanford University665 active studies to explore
Study Responsible Party
Edward E. Manche, Principal Investigator, Professor of Ophthalmology, Stanford University
Study Central Contact
Contact: Edward Manche, MD, 16504987020, [email protected]
1 Study Locations in 1 Countries

California

Byers Eye Institute at Stanford, Palo Alto, California, 94303, United States
Edward Manche, MD, Contact, 650-868-0912, [email protected]
Edward Manche, MD, Principal Investigator